Community‐Based Therapeutic Care for Severe Acute Malnutrition: Rethinking Clinical Paradigms, Health Systems, and the Moral Imperative of Decentralised Treatment
Authors/Creators
Description
Severe acute malnutrition (SAM) remains one of the most urgent yet persistently underrecognized threats to child survival in low-income countries, affecting approximately 13 million children under five years of age and contributing to 1–2 million preventable deaths each year. For decades, the standard approach to SAM has relied on inpatient, hospital‐based treatment following World Health Organization protocols. While clinically sound under ideal conditions, this model has consistently failed in the settings where SAM is most prevalent: crowded, understaffed, and poorly resourced district hospitals. Case fatality rates in such facilities have remained stubbornly between 20% and 30%, and coverage—the proportion of affected children who actually receive care—has often fallen below 10%.
This paper argues for a fundamental reorientation of SAM services away from exclusive inpatient care and toward a community‐based therapeutic care (CTC) model. CTC integrates four core elements: community mobilisation to encourage early presentation, outpatient supplementary feeding for moderate acute malnutrition, outpatient therapeutic protocols with ready‐to‐use therapeutic foods (RUTFs) for uncomplicated SAM, and inpatient care reserved only for those with life‐threatening complications. Drawing on programme data from Malawi, Ethiopia, Sudan, and Niger between 2001 and 2005—involving over 23,000 children—the paper demonstrates that CTC achieves case fatality rates of approximately 4%, recovery rates of nearly 80%, and population coverage exceeding 70%. These results represent a dramatic improvement over traditional models and, crucially, have been sustained during transitions from NGO-led emergency programmes to routine Ministry of Health implementation.
The paper then examines the determinants of successful treatment, emphasising that early presentation—more than any specific clinical protocol—is the single most important predictor of recovery. RUTF, an oil‐based, energy‐dense paste with low water activity, has proven transformative because it requires no refrigeration, resists bacterial contamination, and can be administered at home by caregivers. Cost‐effectiveness estimates range from US12toUS12toUS132 per life‐year gained, comparing favourably with established child survival interventions such as vitamin A distribution or oral rehydration therapy.
Nevertheless, the paper concludes with a note of cautious realism. Technical solutions alone are insufficient. Achieving scale requires that SAM be recognised as a distinct cause of death in mortality surveillance, that the term “acute malnutrition” be adopted to differentiate this condition from chronic stunting, that MUAC be integrated into routine growth monitoring and Integrated Management of Childhood Illness (IMCI) protocols, and that funding priorities shift to reflect the true burden of disease. The ethical imperative is clear: we now possess cost‐effective, high‐impact tools. What remains is the professional and political will to deploy them.